Variant report
Variant | nsv977727 |
---|---|
Chromosome Location | chr15:62374493-62375202 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:62372730..62374756-chr15:62378857..62380874,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-VPS13C-3 | chr15:62374649-62375504 | NONHSAT044267 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs151214752 | chr15:62374505-62374506 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10519154 | chr15:62374526-62374527 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs529988388 | chr15:62374537-62374538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140384923 | chr15:62374585-62374586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1436963 | chr15:62374593-62374594 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs569893963 | chr15:62374622-62374623 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186320192 | chr15:62374642-62374643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576991856 | chr15:62374682-62374683 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs574249555 | chr15:62374699-62374700 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs541366713 | chr15:62374705-62374706 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs552960814 | chr15:62374719-62374720 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs7402469 | chr15:62374729-62374730 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs150357259 | chr15:62374739-62374740 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs542175207 | chr15:62374743-62374744 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs17271389 | chr15:62374877-62374878 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs542772687 | chr15:62374878-62374879 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs4775457 | chr15:62374915-62374916 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs191610941 | chr15:62374936-62374937 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs12438803 | chr15:62374942-62374943 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs138032472 | chr15:62374974-62374975 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs533184137 | chr15:62374977-62374978 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs551446689 | chr15:62375017-62375018 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs4775458 | chr15:62375036-62375037 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs142476435 | chr15:62375068-62375069 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs561384214 | chr15:62375069-62375070 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs75005431 | chr15:62375070-62375071 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs567775560 | chr15:62375096-62375097 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs373947132 | chr15:62375111-62375112 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs368246907 | chr15:62375123-62375124 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs183613788 | chr15:62375141-62375142 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs577688790 | chr15:62375168-62375169 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs538670911 | chr15:62375184-62375185 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs146468711 | chr15:62375185-62375186 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs575270819 | chr15:62375186-62375187 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs139035781 | chr15:62375194-62375195 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21341218 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Mental retardation | 17124404 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:62367800-62379800 | Weak transcription | Pancreas | Pancrea |
2 | chr15:62373200-62379200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr15:62374000-62376200 | Enhancers | Fetal Intestine Small | intestine |
4 | chr15:62374800-62376200 | Enhancers | Fetal Intestine Large | intestine |
5 | chr15:62375200-62376000 | Enhancers | Rectal Mucosa Donor 31 | rectum |